All Stories

  1. Parasites’ immunomodulators: a breakthrough in immunotherapeutics displaying antineoplastic activity against human colorectal and hepatocellular carcinoma cells

    Article • Infectious Agents and Cancer, December 2025, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  2. Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions

    Article • Infectious Agents and Cancer, July 2025, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  3. Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies

    Article • Medical Oncology, May 2025, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  4. Relationship between parasites and lung cancer: Unveiling the link

    Article • Tropical Medicine & International Health, May 2025, Wiley

    Professor MAHA Mohamed EISSA

  5. Unveiling the anti-neoplastic potential of Schistosoma mansoni-derived antigen against breast cancer: a pre-clinical study

    Article • European Journal of Medical Research, April 2025, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  6. Parasites revive hope for cancer therapy

    Article • European Journal of Medical Research, October 2024, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  7. Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis

    Article • Inflammopharmacology, December 2023, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  8. Shedding light on a mysterious link between Toxoplasma gondii and cancer: A review

    Article • Experimental Parasitology, July 2023, Elsevier

    Professor MAHA Mohamed EISSA

  9. Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting

    Article • Infectious Agents and Cancer, April 2023, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  10. Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide

    Article • Medical Oncology, April 2023, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  11. Evaluation of cytotoxic activity of live toxoplasma gondii tachyzoites and toxoplasma antigen on MCF-7 human breast cancer cell line

    Article • EUREKA Life Sciences, March 2022, OU Scientific Route

    Professor MAHA Mohamed EISSA

  12. Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model

    Article • Acta Tropica, January 2022, Elsevier

    Professor MAHA Mohamed EISSA

  13. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni

    Article • Acta Tropica, December 2020, Elsevier

    Professor MAHA Mohamed EISSA

  14. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni

    Article • Parasites & Vectors, September 2020, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  15. Praziquantel lipid nanocapsules

    Article • International Journal of Nanomedicine, August 2018, Dove Medical Press

    Professor MAHA Mohamed EISSA, Rokaya Amara, Riham El-Moslemany, Alyaa Ramadan

  16. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer

    Article • Investigational New Drugs, May 2018, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  17. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens

    Article • PLoS Neglected Tropical Diseases, August 2017, PLOS

    Professor MAHA Mohamed EISSA

  18. Repositioning of chlorambucil as a potential anti-schistosomal agent

    Article • Acta Tropica, February 2017, Elsevier

    Professor MAHA Mohamed EISSA

  19. Anti-Arthritic Activity of Schistosoma mansoni and Trichinella spiralis Derived-Antigens in Adjuvant Arthritis in Rats: Role of FOXP3+ Treg Cells

    Article • PLOS One, November 2016, PLOS

    Professor MAHA Mohamed EISSA

  20. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni -induced liver fibrosis in mice

    Article • Life Sciences, October 2016, Elsevier

    Professor MAHA Mohamed EISSA

  21. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni

    Article • Acta Tropica, July 2016, Elsevier

    Riham El-Moslemany, Professor MAHA Mohamed EISSA

  22. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study

    Article • PLOS One, November 2015, PLOS

    Riham El-Moslemany, Professor MAHA Mohamed EISSA

  23. Could miltefosine be used as a therapy for toxoplasmosis?

    Article • Experimental Parasitology, October 2015, Elsevier

    Professor MAHA Mohamed EISSA

  24. The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice

    Article • Journal of Parasitic Diseases, September 2014, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  25. Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis

    Article • Journal of Parasitic Diseases, August 2014, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  26. Miltefosine for Old World cutaneous leishmaniasis: An experimental study on Leishmania major infected mice

    Article • Alexandria Journal of Medicine, September 2012, Elsevier

    Professor MAHA Mohamed EISSA

  27. Initial characterization of an autoclaved Toxoplasma vaccine in mice

    Article • Experimental Parasitology, July 2012, Elsevier

    Professor MAHA Mohamed EISSA

  28. Giardia lamblia: A new target for miltefosine

    Article • International Journal for Parasitology, May 2012, Elsevier

    Professor MAHA Mohamed EISSA

  29. Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis

    Article • Experimental Parasitology, August 2011, Elsevier

    Professor MAHA Mohamed EISSA

  30. Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy

    Article • Parasites & Vectors, May 2011, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  31. Miltefosine, a promising novel agent for schistosomiasis mansoni

    Article • International Journal for Parasitology, February 2011, Elsevier

    Professor MAHA Mohamed EISSA

  32. Synthesis and biological evaluation of a novel class as antileishmanial agent

    Article • Medicinal Chemistry Research, December 2010, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  33. Inheritance of Schistosoma mansoni infection incompatibility in Biomphalaria alexandrina snails

    Article • Memórias do Instituto Oswaldo Cruz, March 2010, FapUNIFESP (SciELO)

    Professor MAHA Mohamed EISSA

  34. Synthesis of Substituted Pyrimidinedione Derivatives as Potential Schistosomicidal Agents

    Article • Letters in Drug Design & Discovery, June 2009, Elsevier

    Professor MAHA Mohamed EISSA

  35. Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis

    Article • Medicinal Chemistry Research, May 2008, Springer Science + Business Media

    Professor MAHA Mohamed EISSA

  36. Topical Application of Ivermectin for Human Ectoparasites

    Article • American Journal of Tropical Medicine and Hygiene, December 1995, American Society of Tropical Medicine and Hygiene

    Professor MAHA Mohamed EISSA